AMLN

AcronymDefinition
AMLNAmerican Mideast Leadership Network (Long Island City, NY)
AMLNAustralian Mobile Learning Network (Australia)
References in periodicals archive ?
Tickers featured: ACOR, ALXN, AMLN, ARYX, AVGN, BIIB, BMRN, CRME, DNDN, GENZ, GILD, MDVN, MITI, MYGN, SQNM, VRTX, XNPT.
Tickers featured: AMLN, BDX, CVS, GSK, JNJ, MRK, NVO, PODD, RHHBY, VVUS, WAG.
Tickers featured: AMLN, BDX, CVS, MHS, MRK, NOVO, PODD, SIRT, WAG.
11 August 2011 - US Amylin Pharmaceuticals Inc (NASDAQ: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes Inc (NASDAQ: ALKS) said on Wednesday that the US Food and Drug Administration (FDA) has acknowledged the firms' BYDUREON (exenatide extended-release for injectable suspension) resubmission.
Tickers featured: AFFX, ALKS, AMGN, AMLN, ARNA, CVTX, DNA, FVRL, GILD, HGSI, ICOS, IMCL, JNJ, LLY, NBIX, NKTR, NTMD, NVS, OSIP, PDLI, PFE, SEPR, SRA.
5 August 2011 - US-based biopharmaceutical company Amylin Pharmaceuticals Inc (NASDAQ: AMLN) and Japan-based Takeda Pharmaceutical Company Limited (TSE: 4502) announced yesterday they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide and metreleptin.
Tickers featured: AMGN, AMLN, ARNA, AZN, BIIB, BMY, CATG, CRME, DNA, GENZ, GILD, IMCL, IYXI, JNJ, KAL, LLY, MRK, MYGN, NBIX, NTMD, NVS, PDLI, PFE, RHHVF, RNVS, SGMO.
22 June 2011 - US-based Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals Inc (NASDAQ: AMLN) and Alkermes Inc (NASDAQ: ALKS) announced yesterday that the European Commission (EC) has granted marketing authorisation to BYDUREON.
Tickers featured: ADA, ALKS, AMLN, CEPH, FRX, IP, JNJ, LLY, MNKD, MNTA, NEOL, NKTR, NSTK, PG.
21 June 2011 - US-based biopharmaceutical company Amylin Pharmaceuticals Inc (NASDAQ: AMLN) said yesterday that it will present data for its two first-in-class diabetes drugs, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, 24-28 June.
9 June 2011 - US Eli Lilly and Company (NYSE: LLY) said on Wednesday the US District Court for the Southern District of California ruled in its favour, vacating a temporary restraining order and denying a request by Amylin Pharmaceuticals (NASDAQ: AMLN) for a preliminary injunction that sought to impose restrictions on the Lilly Diabetes sales force and other relief.